$ASNS

Actelis Networks Inc (ASNS) Stock Price, Quote, News & History

This article provides an overview of Actelis Networks Inc (ASNS) stock, including its current price, news, financial data, and analyst ratings. It highlights recent news about the stock's movements, such as a surge after a reported revenue rebound and an expanded share repurchase program, as well as a jump following a new order from a Japanese government entity for its MetaLight networking solutions. Key financial statistics and comparisons with competitors are also included.

Original reporting
Published Mar 20, 2026, 2:08 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Mar 20, 2026, 2:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ASNS
Bullish
medium confidence
Mentioned
$ASNS
Relevance
6/10
AlphAI data visualization · based on Benzinga
Decision brief

The 30-second read

$ASNSBullishMed
01

Why it matters

The recent order from Japan signifies international expansion and validation of products, likely to support future revenue growth.

02

Market read

The news is highly relevant for investors focusing on technology and international growth, with potential influence on stock price and sector sentiment.

03

What to watch

Potential delays in order fulfillment or revenue recognition issues could temper gains.

Relevance 6/10Timing: Immediate to short-term

Background

Actelis Networks Inc specializes in networking solutions, with recent positive financial and operational news boosting investor confidence.

Company-level read

Ticker impact

$ASNSBullishMedium confidence
Context

High relevance due to recent positive news and increased trading activity.

Expected impact

Moderate upward movement expected in the short term, with potential for continued gains if positive catalysts persist.

Evidence & confidence

Recent news indicates favorable developments, but stock price reactions can be influenced by broader market conditions and investor sentiment.

Market effects

Positive sentiment for the networking and technology sectors, potentially boosting related stocks.

Japanese government order may enhance visibility and credibility in Asian markets.

Limited; specific to company and regional order.

Counterpoint

The stock may be overextended due to short-term hype; a correction could occur if broader market sentiment turns negative.

Key entities

  • Actelis Networks Inc

    Networking solutions provider.

  • Japanese Government Entity

    Official customer placing significant order.

Related articles

$ASNSMed

Actelis Networks Reports Second Quarter 2026 Financial Results and Provides Business Update

ACTELIS NETWORKS INC (ASNS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Actelis Networks Reports Second Quarter 2026 Financial Results and Provides Business Update Revenues were up 20% year over year, reaching $1.1 million in the second quarter of 2026; gross margin was 51%, compared to 32% in the second quarter of 2025 New wins across I

$CEROHighAI 8/10

Delisting of Securities from The Nasdaq Stock Market

Nasdaq said it will delist multiple issuers’ securities from the Nasdaq Stock Market, including CERo Therapeutics Holdings, Bowen Acquisition Corp, Graphjet Technology, Blue Hat Interactive Entertainment Technology, X3 Holdings Co, Captivision Inc, Actelis Networks, American Rebel Holdings, Reviva Pharmaceuticals, Alchemy Investments Acquisition Corp 1, Bitcoin Depot, Inotiv, GoHealth, Functional Brands, Sleep Number, Smart Digital Group, and REE Automotive. Most were suspended in 2025-2026 and

$LLYLow

Nektar v. Lilly: Lilly Defeats CRE Claim, But Jury Finds It Owes $90M For Breaching The Implied Covenant Of Good Faith And Fair Dealing

A federal jury ruled that Eli Lilly & Co. breached the implied covenant of good faith and fair dealing with Nektar Therapeutics, awarding Nektar $90 million in damages. The jury rejected Nektar's claim that Lilly breached the license agreement's commercially reasonable efforts (CRE) obligation. Lilly plans to appeal, arguing no liability should have been imposed. The case highlights risks in biopharma licensing agreements.

$EQNRMed

Galp Energia and Equinor Get Offshore Brazilian Oil Block

Galp Energia and Equinor have been awarded an offshore oil block in Brazil's Santos Basin. Galp will own 30% of the Rodocrosita block, with Equinor operating the remaining 70%. The companies may explore synergies with the adjacent Bacalhau project, which is ramping up production and will contribute 40,000 barrels per day to Galp once fully operational.

$PINSMed

Pinterest (PINS), Why Is It Back In The Spotlight?

Pinterest (PINS) appointed Amazon's James Dibbo as its new CFO. The company's stock has shown mixed performance, with a recent 7-day return of 7.52% but a 1-year return of -36.11%. Analysts have varying views on its valuation, with some seeing it as undervalued at $20.31 per share compared to a fair value estimate of $29.05, while others note its high P/E ratio of 46.2x.